Angeles Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Buy |
1,284
+29
| +2% | +$12.9K | 0.04% | 171 |
|
|
2025
Q1 | $608K | Buy |
1,255
+208
| +20% | +$101K | 0.05% | 127 |
|
|
2024
Q4 | $422K | Sell |
1,047
-67
| -6% | -$27K | 0.03% | 159 |
|
|
2024
Q3 | $518K | Sell |
1,114
-8
| -0.7% | -$3.72K | 0.04% | 132 |
|
|
2024
Q2 | $526K | Buy |
1,122
+55
| +5% | +$25.8K | 0.05% | 124 |
|
|
2024
Q1 | $446K | Buy |
1,067
+230
| +27% | +$96.1K | 0.04% | 126 |
|
|
2023
Q4 | $341K | Buy |
837
+3
| +0.4% | +$1.22K | 0.04% | 139 |
|
|
2023
Q3 | $290K | Sell |
834
-30
| -3% | -$10.4K | 0.04% | 135 |
|
|
2023
Q2 | $304K | Buy |
864
+46
| +6% | +$16.2K | 0.04% | 139 |
|
|
2023
Q1 | $258K | Sell |
818
-192
| -19% | -$60.5K | 0.04% | 147 |
|
|
2022
Q4 | $292K | Buy |
1,010
+231
| +30% | +$66.7K | 0.05% | 130 |
|
|
2022
Q3 | $226K | Buy |
+779
| New | +$226K | 0.04% | 141 |
|